Medicines, Ethics and Practice (MEP)

Your go-to guide for good practice

No long lists of statutory obligations here – just everyday, practical tools and guidance to help you make the right decisions.

When to dispense medicines. When not to. When to raise an alarm.

With the MEP by your side, you’ll feel confident you’re making the right decisions.


Would you like to contribute to improving future issues of MEP?

Email us to learn more about joining our advisory panel: [email protected]

Download your MEP here

MEP637000714037982944

Non-members can purchase a copy of the MEP from the Pharmaceutical Press.

NOTE: The publication of MEP 44 has been postponed until July 2021 as a result of the coronavirus pandemic.

Details of significant changes/additions will be posted below.  

If you have any queries please contact RPS Support: [email protected]

12 months of membership for the price of 11

We all feel like we've missed out in 2020, so we want to give you something back for 2021.

Get your 12 months of RPS membership for the price of 11, when you renew before 28 February, using annual direct debit. That’s an extra month, completely free, saving you up to £19!

Over that 12 months you'll get:

  • An exciting program of vital webinars (at least one webinar a week!)
  • Our brand new digital MEP, coming in 2021
  • All the support you need during COVID-19.

With your support, we can continue advocating for pharmacy in the coming year and supporting our members everywhere.

Renew your membership today!

MEP 43 corrections

Amendments in italics, additions and new information

Page

Content

Changes

56

Patient Group Directions (PGDs)

Guidance for provisionally registered pharmacists on operating under PGDs is available from Specialist Pharmacy Service.

59

Pandemic exemptions

See RPS COVID-19 pages for the latest information. Includes guidance on ‘Ethical, professional decision-making in the COVID-19 pandemic’, and guidance on controlled drugs contingency legislation for: ‘Emergency supply of controlled drugs’, ‘Supply of controlled drugs under a Serious Shortage Protocol’, and ‘Changing the intervals of instalments during a pandemic’.

66

Dispensing sodium valproate for girls and women

When supplying valproate, pharmacists should also:

  • Provide a patient card every time valproate is dispensed
  • Dispense valproate preparations in original packs whenever possible.

If dispensing in 'white boxes' ensure a patient information leaflet is provided and a valproate warning label/sticker added to the box

70

Optometrist independent prescriber - other applicable considerations

Optometrist independent prescriber - other applicable considerations

Amend to read: For ocular conditions affecting the eye and surrounding tissue only (but not parenteral preparations)

70

Supplementary prescriber

Paramedics should be added to the list of Supplementary Prescribers

109 - 110

Cannabidiol products

A licensed cannabidiol preparation is now available. Epidyolex - a schedule 5 controlled drug, is licensed for use as an adjunct therapy of seizures associated with Lennon-Gastaut syndrome or Dravet syndrome in conjunction with clobazam, for patients 2 years of age and older. Further information on the use of Epidyolex can be found in the Summary of Product Characteristics.

Have you visited our e-Library?

Cpd

The MEP is just one of the essential texts we offer.

Our e-Library, which is free to use for all members, offers many other essential texts, such as Dale and Appelbe's Pharmacy and Medicines Law.

Browse the RPS e-Library